Stoke Therapeutics (STOK) Receivables - Other: 2022-2025
Historic Receivables - Other for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to $1.6 million.
- Stoke Therapeutics' Receivables - Other rose 129.96% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 129.96%. This contributed to the annual value of $700,000 for FY2024, which is 993.75% up from last year.
- Latest data reveals that Stoke Therapeutics reported Receivables - Other of $1.6 million as of Q3 2025, which was down 2.03% from $1.6 million recorded in Q2 2025.
- Over the past 5 years, Stoke Therapeutics' Receivables - Other peaked at $1.6 million during Q2 2025, and registered a low of $11,000 during Q1 2024.
- Over the past 3 years, Stoke Therapeutics' median Receivables - Other value was $492,000 (recorded in 2023), while the average stood at $573,818.
- Its Receivables - Other has fluctuated over the past 5 years, first slumped by 97.76% in 2024, then spiked by 5,409.09% in 2025.
- Over the past 4 years, Stoke Therapeutics' Receivables - Other (Quarterly) stood at $588,000 in 2022, then plummeted by 89.12% to $64,000 in 2023, then spiked by 993.75% to $700,000 in 2024, then skyrocketed by 129.96% to $1.6 million in 2025.
- Its Receivables - Other was $1.6 million in Q3 2025, compared to $1.6 million in Q2 2025 and $606,000 in Q1 2025.